Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,027 public trials 1,169 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, Not Recruiting

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

NCT02673333

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
Locations: University of Michigan (Data or Specimen Analysis Only) Ann Arbor, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma

NCT04039607

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Local Institution - 0292 Tucson, Arizona, United States

Local Institution - 0288 Coronado, California, United States

Local Institution - 0157 Duarte, California, United States

Local Institution - 0077 Washington D.C., District of Columbia, United States

View all 210 locations

View Trial Details

Active, Not Recruiting

Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy

NCT05703269

Conditions: Adenocarcinoma, Brain Diseases, Brain Metastases, Adult, +46 more
Locations: Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States

Decatur Memorial Hospital Decatur, Illinois, United States

Crossroads Cancer Center Effingham, Illinois, United States

HSHS Saint Elizabeth's Hospital O'Fallon, Illinois, United States

View all 34 locations

View Trial Details

Active, Not Recruiting

Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients

NCT03916627

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Active, Not Recruiting

The AUS-PREDICT Registry for DCIS Patients With DCISionRT Testing

NCT04916808

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
Locations: GenesisCare Alexandria, New South Wales, Australia

Royal Melbourne Hospital Parkville, Victoria, Australia

View Trial Details

Active, Not Recruiting

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

NCT03355976

Conditions: Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +28 more
Locations: University of Illinois Chicago Chicago, Illinois, United States

Rhode Island Hospital Providence, Rhode Island, United States

Women & Infants Hospital Providence, Rhode Island, United States

The Miriam Hospital Providence, Rhode Island, United States

View Trial Details

Active, Not Recruiting

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

NCT02664883

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer

NCT03680508

Conditions: Adenocarcinoma, Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, +11 more
Locations: University of Hawaii Honolulu, Hawaii, United States

Oregon Health & Science University Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Active, Not Recruiting

Evaluation of a Simple-Prep Controlled Embolic

NCT06453642

Conditions: Adenocarcinoma, Angiomyolipoma, Bone Diseases, +30 more
Locations: University of California San Diego Altman Clinical and Translation Research Institute La Jolla, California, United States

University of Colorado Anschutz Medical Campus Aurora, Colorado, United States

Northwestern University Chicago, Illinois, United States

Indiana University Hospital Indianapolis, Indiana, United States

View all 20 locations

View Trial Details

Active, Not Recruiting

Targeted Therapy and Avelumab in Merkel Cell Carcinoma

NCT04261855

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations: Mid North Coast Cancer Institute - Coffs Harbour Health Campus Coffs Harbour, New South Wales, Australia

Lake Macquarie Private Hospital Gateshead, New South Wales, Australia

Gosford Hospital Gosford, New South Wales, Australia

Wyong Hospital Hamlyn Terrace, New South Wales, Australia

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions